ArticleCardiovascular drugs and therapy2024

IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway.

Zhang Qian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.